Alcohol Withdrawal and AUD Relapse Prevention Case | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Case Discussion ](https://mdster.com/blog?category=case-discussion) 4. Alcohol Withdrawal Case: Detox, Craving, and Relapse Prevention [ Case Discussion ](https://mdster.com/blog?category=case-discussion) Alcohol Withdrawal Case: Detox, Craving, and Relapse Prevention ================================================================= A board-focused psychiatry case discussion on acute withdrawal, biomarkers, neuroadaptation, and AUD pharmacotherapy. [ MDster Editorial Team ](https://mdster.com/about) · Jun 20, 2026 · 6 min read · 15 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Board Review ](https://mdster.com/blog?tag=board-review) [ Alcohol Withdrawal ](https://mdster.com/blog?tag=alcohol-withdrawal) [ Addiction Medicine ](https://mdster.com/blog?tag=addiction-medicine) [ Psychiatry ](https://mdster.com/blog?tag=psychiatry) ![Alcohol Withdrawal Case: Detox, Craving, and Relapse Prevention](https://mdster.com/storage/blog/images/alcohol-withdrawal-case-detox-craving-and-relapse-prevention.jpg) Share this article Share this post On this page 1. [ Alcohol Withdrawal Diagnosis at the Bedside ](#alcohol-withdrawal-diagnosis-at-the-bedside) 2. [ Differential diagnosis that must stay active ](#differential-diagnosis-that-must-stay-active) 3. [ Immediate Pharmacologic Priorities ](#immediate-pharmacologic-priorities) 4. [ Interpreting the Alcohol Biomarkers ](#interpreting-the-alcohol-biomarkers) 5. [ Why Symptoms Persist After Detox ](#why-symptoms-persist-after-detox) 6. [ From impulsivity to compulsivity ](#from-impulsivity-to-compulsivity) 7. [ Choosing Relapse-Prevention Pharmacotherapy ](#choosing-relapse-prevention-pharmacotherapy) 8. [ Discharge Plan That Actually Reduces Relapse ](#discharge-plan-that-actually-reduces-relapse) 9. [ Key Points for Board Exams ](#key-points-for-board-exams) 10. [ Conclusion ](#conclusion) 11. [ Frequently Asked Questions ](#blog-faqs) 12. [ References ](#references-heading) On this page 1. [ Alcohol Withdrawal Diagnosis at the Bedside ](#alcohol-withdrawal-diagnosis-at-the-bedside) 2. [ Differential diagnosis that must stay active ](#differential-diagnosis-that-must-stay-active) 3. [ Immediate Pharmacologic Priorities ](#immediate-pharmacologic-priorities) 4. [ Interpreting the Alcohol Biomarkers ](#interpreting-the-alcohol-biomarkers) 5. [ Why Symptoms Persist After Detox ](#why-symptoms-persist-after-detox) 6. [ From impulsivity to compulsivity ](#from-impulsivity-to-compulsivity) 7. [ Choosing Relapse-Prevention Pharmacotherapy ](#choosing-relapse-prevention-pharmacotherapy) 8. [ Discharge Plan That Actually Reduces Relapse ](#discharge-plan-that-actually-reduces-relapse) 9. [ Key Points for Board Exams ](#key-points-for-board-exams) 10. [ Conclusion ](#conclusion) 11. [ Frequently Asked Questions ](#blog-faqs) 12. [ References ](#references-heading) Ten hours after abruptly stopping a pint of vodka daily, this 42-year-old is diaphoretic, hypertensive, tachycardic, tremulous, and hearing “whispers” in ambient noise. The immediate danger is not craving; it is progression to seizure or delirium tremens while the team is distracted by liver tests and guilt. Alcohol Withdrawal Diagnosis at the Bedside ------------------------------------------- The timing and autonomic phenotype make **acute alcohol withdrawal** the leading diagnosis. He is oriented, anxious, tremulous, mildly febrile, and has perceptual distortion without global delirium. That places him closer to uncomplicated or early complicated withdrawal than delirium tremens. ### Differential diagnosis that must stay active - Alcohol withdrawal with early hallucinosis - Sedative-hypnotic withdrawal, especially if undisclosed benzodiazepine use - Stimulant intoxication or sympathomimetic exposure - Serotonin toxicity, given intermittent sertraline, though clonus and hyperreflexia are absent - Sepsis, thyrotoxicosis, hypoglycemia, hepatic encephalopathy, or intracranial pathology Use CIWA-Ar only when the patient can participate reliably. If delirious, intubated, psychotic, or medically unstable, fixed-dose or objective-sedation protocols are safer than pretending CIWA is precise. Immediate Pharmacologic Priorities ---------------------------------- Benzodiazepines are the core treatment because they restore GABAergic tone and reduce risk of seizures and delirium. ASAM supports symptom-triggered benzodiazepine treatment when monitoring is available; longer-acting agents are often preferred, while lorazepam is practical when hepatic reserve is uncertain. [\[1\]](#cite-1 "Reference [1]") Initial management should include: 1. Diazepam or lorazepam titrated to withdrawal severity, respiratory status, and sedation. 2. IV or IM thiamine before or with carbohydrate-containing fluids; do not delay emergent glucose for hypoglycemia. 3. Magnesium, potassium, phosphate, volume status, glucose, CBC, CMP, LFTs, INR, and ECG when clinically indicated. 4. Low-stimulation environment, frequent reassessment, and escalation if escalating benzodiazepine needs suggest severe withdrawal. > **Clinical Pearl:** Clonidine or beta-blockers may improve autonomic noise, but they do not prevent withdrawal seizures. If you use them, use them as adjuncts—not as disguised monotherapy. Interpreting the Alcohol Biomarkers ----------------------------------- His AST 145, ALT 65, GGT 210, MCV 102, and elevated CDT support chronic heavy alcohol exposure. The AST:ALT ratio above 2 is compatible with alcohol-associated liver injury, but these tests are not diagnostic in isolation. CDT and GGT are useful for corroboration and relapse monitoring, but each has limitations. Contemporary reviews note that indirect markers such as AST, ALT, GGT, MCV, and CDT vary in sensitivity and specificity and are affected by liver disease, hematologic disease, medications, and metabolic factors. [\[2\]](#cite-2 "Reference [2]") FindingBoard interpretationAST > ALTSuggests alcohol-associated hepatic injury, especially when ratio is >2GGT elevationSensitive to heavy use but nonspecificCDT elevationSupports sustained heavy drinking over recent weeks Why Symptoms Persist After Detox -------------------------------- By day 2, vital signs may normalize while anxiety, insomnia, dysphoria, and craving remain intense. Chronic alcohol exposure enhances inhibitory GABA-A signaling and suppresses glutamatergic NMDA activity; the adapted brain compensates in the opposite direction. Abrupt cessation unmasks a hyperexcitable, stress-sensitized state. NIAAA describes addiction progression as a shift from positive reinforcement toward negative reinforcement, where drinking is increasingly driven by relief of withdrawal-related distress rather than pleasure. [\[3\]](#cite-3 "Reference [3]") ### From impulsivity to compulsivity Early use is reward-driven: alcohol increases mesolimbic dopamine signaling from the VTA to nucleus accumbens, partly through endogenous opioid mechanisms. Over time, prefrontal control weakens, ventral striatal reward behavior shifts toward dorsal striatal habit circuitry, and the patient drinks to feel “less awful.” That framing matters clinically. A nonjudgmental explanation is not soft psychiatry; it improves alliance, reduces shame, and supports adherence. Choosing Relapse-Prevention Pharmacotherapy ------------------------------------------- Acamprosate is reasonable here because he is abstinent after detox, wants abstinence, has elevated transaminases, and reports anxiety/insomnia that may trigger relapse. Its exact mechanism is not fully settled, but labeling and reviews describe modulation of glutamate/NMDA-related hyperexcitability with possible GABA effects; it is primarily renally cleared and requires renal assessment. [\[4\]](#cite-4 "Reference [4]") Naltrexone is a mu-opioid receptor antagonist that reduces alcohol reward and heavy drinking risk. It is often excellent when the goal is reduced heavy drinking, but avoid it in current opioid use and be cautious in significant hepatic disease. NIAAA and APA identify naltrexone and acamprosate as evidence-based medications for AUD treatment. [\[5\]](#cite-5 "Reference [5]") Disulfiram inhibits aldehyde dehydrogenase and creates an aversive acetaldehyde reaction if alcohol is consumed. In this patient, impulsive relapse risk, depression, hypertension, and abnormal liver enzymes make unsupervised disulfiram unattractive. NICE also emphasizes hepatotoxicity counseling and careful patient selection. [\[6\]](#cite-6 "Reference [6]") Discharge Plan That Actually Reduces Relapse -------------------------------------------- A detox-only admission is incomplete care. The transition plan should be written before discharge, not vaguely recommended afterward. - Continue acamprosate with renal monitoring and adherence planning. - Reassess major depressive disorder after sustained abstinence; optimize sertraline or psychiatric treatment if symptoms persist. - Begin CBT or motivational enhancement therapy focused on triggers, cravings, sleep, and refusal skills. - Offer mutual aid options, including AA, SMART Recovery, or recovery coaching. - Involve his wife if safe and acceptable; couples-based support can reduce environmental relapse triggers. - Track relapse risk with self-report plus objective markers such as GGT, CDT, or PEth when clinically useful. Key Points for Board Exams -------------------------- - Treat alcohol withdrawal first with benzodiazepines and thiamine-supported medical stabilization. - Mild auditory illusions with intact orientation are not delirium tremens. - AST>ALT, GGT, MCV, and CDT support chronic heavy use but are not standalone diagnostic tests. - Protracted withdrawal reflects persistent GABA-glutamate and stress-system dysregulation. - Acamprosate supports abstinence; naltrexone blunts reward; disulfiram requires high motivation and supervision. - The best answer to “Is this a moral failing?” is biologically accurate, empathic, and responsibility-preserving. Conclusion ---------- This case tests the whole arc of AUD care: acute detox, neurobiology, medication selection, and relapse prevention. The winning SOE answer is not “give lorazepam and discharge.” It is stabilizing the hyperadrenergic brain, explaining the compulsive cycle without blame, and building a durable outpatient treatment scaffold. Frequently Asked Questions ---------------------------- ### When should lorazepam be preferred over diazepam in alcohol withdrawal? Lorazepam is often preferred when hepatic impairment, older age, or oversedation risk makes long-acting benzodiazepines less attractive. ### Does an elevated CDT prove alcohol relapse? No. CDT supports sustained heavy alcohol exposure, but interpretation should include history, other biomarkers, liver status, and assay limitations. ### Why is acamprosate chosen after detox rather than during severe withdrawal? Acamprosate is for maintenance of abstinence, not acute seizure prevention. Benzodiazepines remain the key medication for acute withdrawal. ### Can naltrexone be used with abnormal liver enzymes? Sometimes, but clinicians should assess severity, trend, synthetic function, and alternatives. It should not be used in acute hepatitis, liver failure, or current opioid use. ### What makes disulfiram risky in this case? His intense cravings, depression, impulsive relapse risk, hypertension, and abnormal liver tests make an alcohol-disulfiram reaction and hepatotoxicity more concerning without close supervision. References (8) ------------------ 1. 1. [ downloads.asam.org/sitefinity-production-blobs/docs/default-source/quality-science/the\_asam\_clinical\_practice\_guideline\_on\_alcohol-1.pdf?sfvrsn=ba255c2\_0 ](https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/quality-science/the_asam_clinical_practice_guideline_on_alcohol-1.pdf?sfvrsn=ba255c2_0) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ pmc.ncbi.nlm.nih.gov/articles/PMC10237590 ](https://pmc.ncbi.nlm.nih.gov/articles/PMC10237590/) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ NIAAA Core Resource: Neuroscience—The Brain in Addiction and Recovery ](https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/neuroscience-brain-addiction-and-recovery) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ DailyMed: Acamprosate Calcium Delayed-Release Tablets ](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9803db35-2600-4f42-80c1-43216fd1ba3d) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ NIAAA Core Resource: Recommend Evidence-Based Treatment—Know the Options ](https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/recommend-evidence-based-treatment-know-options) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ www.nice.org.uk/guidance/cg115/chapter/Recommendations ](https://www.nice.org.uk/guidance/cg115/chapter/Recommendations) [↩](#cite-ref-6-1 "Back to text") 7. 7. [ ASAM Clinical Practice Guideline on Alcohol Withdrawal Management, 2020 ](https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/quality-science/the_asam_clinical_practice_guideline_on_alcohol-1.pdf) 8. 8. [ APA Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder ](https://pmc.ncbi.nlm.nih.gov/articles/PMC6527005/) Study pathway Build momentum in Psychiatry with a focused study pathway ----------------------------------------------------------- - Exam‑style questions for Psychiatry - Smart review to target weak topics - Progress tracking that keeps you accountable Free 5-day trial No credit card required. [ Start your free trial ](https://mdster.com/user/dashboard) [ Explore Psychiatry ](https://mdster.com/speciality/psychiatry) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Board Review ](https://mdster.com/blog?tag=board-review) [ # Alcohol Withdrawal ](https://mdster.com/blog?tag=alcohol-withdrawal) [ # Addiction Medicine ](https://mdster.com/blog?tag=addiction-medicine) [ # Psychiatry ](https://mdster.com/blog?tag=psychiatry) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Case Discussion ----------------------- [ See all ](https://mdster.com/blog?category=case-discussion) [### Pediatric Acute Severe Asthma: ED Case Discussion 4 min read Jun 18, 2026 ](https://mdster.com/blog/pediatric-acute-severe-asthma-ed-case-discussion) [### Bronchiolitis to Pediatric Shock: PEWS, I-PASS, Resuscitation 6 min read Jun 16, 2026 ](https://mdster.com/blog/bronchiolitis-to-pediatric-shock-pews-i-pass-resuscitation) [### Suspected LVO Stroke: EMS Destination, BP, and Reperfusion 5 min read Jun 14, 2026 ](https://mdster.com/blog/suspected-lvo-stroke-ems-destination-bp-and-reperfusion) Related Posts ------------- [ ![Drug Metabolism in Liver Disease: Anesthesia Board Pearls](https://mdster.com/storage/blog/images/drug-metabolism-in-liver-disease-anesthesia-board-pearls.jpg) Medical Education ### Drug Metabolism in Liver Disease: Anesthesia Board Pearls Learn how liver disease changes anesthetic drug handling, including albumin binding, extraction ratios, clearance, and prolonged sedation risk. 5 min read 0 comments ](https://mdster.com/blog/drug-metabolism-in-liver-disease-anesthesia-board-pearls) [ ![Pediatric Acute Severe Asthma: ED Case Discussion](https://mdster.com/storage/blog/images/pediatric-acute-severe-asthma-ed-case-discussion.jpg) Case Discussion ### Pediatric Acute Severe Asthma: ED Case Discussion A board-focused pediatric asthma case covering severity classification, ED stabilization, differential diagnosis, discharge readiness, and action-plan teaching. 4 min read 0 comments ](https://mdster.com/blog/pediatric-acute-severe-asthma-ed-case-discussion) [ ![Risk in Psychosis, Mania, and Substance Use: A Practical Guide](https://mdster.com/storage/blog/images/risk-in-psychosis-mania-and-substance-use-a-practical-guide.jpg) Medical Education ### Risk in Psychosis, Mania, and Substance Use: A Practical Guide A high-yield psychiatry guide to assessing acute risk in psychosis, mania, and substance use, with board-focused management planning pearls. 6 min read 0 comments ](https://mdster.com/blog/risk-in-psychosis-mania-and-substance-use-a-practical-guide) [ ![Bronchiolitis to Pediatric Shock: PEWS, I-PASS, Resuscitation](https://mdster.com/storage/blog/images/bronchiolitis-to-pediatric-shock-pews-i-pass-resuscitation.jpg) Case Discussion ### Bronchiolitis to Pediatric Shock: PEWS, I-PASS, Resuscitation Case-based review of an infant with bronchiolitis who deteriorates overnight into decompensated shock, highlighting PEWS triggers and I-PASS failures. 6 min read 0 comments ](https://mdster.com/blog/bronchiolitis-to-pediatric-shock-pews-i-pass-resuscitation) [ ![Ovarian Aging and Follicular Depletion in Menopause](https://mdster.com/storage/blog/images/ovarian-aging-and-follicular-depletion-in-menopause.jpg) Medical Education ### Ovarian Aging and Follicular Depletion in Menopause Understand ovarian aging as a follicle-depletion syndrome driving FSH rise, irregular cycles, vasomotor symptoms, and accelerated bone loss. 6 min read 0 comments ](https://mdster.com/blog/ovarian-aging-and-follicular-depletion-in-menopause) [ ![Suspected LVO Stroke: EMS Destination, BP, and Reperfusion](https://mdster.com/storage/blog/images/suspected-lvo-stroke-ems-destination-bp-and-reperfusion.jpg) Case Discussion ### Suspected LVO Stroke: EMS Destination, BP, and Reperfusion A 68-year-old with aphasia and hemiplegia forces a high-stakes EMS decision: closer thrombolysis or direct thrombectomy-capable stroke care. 5 min read 0 comments ](https://mdster.com/blog/suspected-lvo-stroke-ems-destination-bp-and-reperfusion) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept